Director's Message


We have hit full stride in our mission to advance genomic medicine through research and education. The Centre’s investments have been instrumental in bringing the University of Toronto to the forefront in genome sequencing and its applications in medicine. We support the world’s largest ‘open science’ genome sequencing project applied to autism. We have enabled a generous partnership between Illumina Inc. and our researchers, for the application of genome sequencing to any family in need of diagnosis. Additional partnerships have been forged with computer science academics and local start-up companies, to develop new infrastructure for storage and analysis of the ‘big data’ generated and its linkage to health records. Recognizing that such advances cascade into needs for delivery of complex findings to families, we are now financing an increased number of training spots for genetic counsellors. With Massey College, we proudly started the new Science Journalism Fellowship, which is unique in Canada. All of these activities link to the Canadian Personal Genome Project, moving forward our mission to illuminate the path for 21st century medical practice. I remain steadfast that each dollar investment be strategic, defined by Robert S. McLaughlin himself as, “one grade only, and that the best”.

STEPHEN SCHERER, PhD DSc FRSC, Director, McLaughlin Centre


Chairs' Message


We are proud to be advisors to the dedicated work by the McLaughlin Centre as it continues to build on a legacy of support for training of physicians and health care professionals, and promotion of health research. Opportunities for funding have been expanded during the past five years, beyond their seminal place in the University of Toronto medical school and teaching hospitals, to encompass allied disciplines from throughout the University, such as computer science, engineering, public health and others. This expansion is particularly with foresight for the burgeoning field of Artificial Intelligence, with its potential to transform so many aspects of medical research and practice. We anticipate a bright future, given the Centre’s substantial endowment with potential to unleash additional scientific funding, and given what we recognize as a strong competitive edge through its impressive members and mentees.

TREVOR YOUNG, MD PhD FRCPC FCAHS, Chair Executive Committee
ALAN BERNSTEIN, OC OOnt PhD FRSC FCAHS, Chair Oversight Committee


Education Program Director’s Message


Genomic medicine is experiencing a revolutionary period, reflected by discoveries enhancing the basic understanding of genomic organization, gene expression, epigenetics and genome variation. The dividends for human health are potentially staggering. The physician scientist occupies a critical niche where genomics research intersects medical science and practice. To move medicine forward, our trainees will need to understand the challenges most relevant to patients and, more broadly, to the healthcare system. They will need to integrate this new found knowledge of genomics with their own research questions informed by the patients they see, so this is where the McLaughlin Centre is making strategic investments.

NORMAN ROSENBLUM, MD FRCPC, Education Program Director, McLaughlin Centre

Visit MD/PhD Program
Visit CREMS Programs


Director, McLaughlin Centre